FDA halts unapproved antihistamines (AP via Yahoo! News)
Manufacturers of cold, cough and allergy medicines that contain the antihistamine carbinoxamine and have not been approved have been given 30 to 90 days to stop making the products.

FDA orders unapproved antihistamine medicines off market (KARE 11 Minneapolis-St. Paul)
Manufacturers of cold, cough and allergy medicines that contain the antihistamine carbinoxamine and have not been approved have been given 30 to 90

FDA Moves to Improve Drug Safety and Quality, Begins with Carbinoxamine (Kansas City InfoZine)
The Food and Drug Administration (FDA) announced the strengthening of its efforts against unapproved drug products. The activity will begin with prescription products containing the antihistamine carbinoxamine because of safety concerns regarding their use in children under 2 years of age.